335 related articles for article (PubMed ID: 14654953)
21. Interleukin-2 and dendritic cells as adjuvants for surgical therapy of tumours associated with human papillomavirus type 16.
Bubeník J; Mikysková R; Vonka V; Mendoza L; Símová J; Smahel M; Indrová M
Vaccine; 2003 Feb; 21(9-10):891-6. PubMed ID: 12547599
[TBL] [Abstract][Full Text] [Related]
22. Local cytokine treatment of HPV16-associated tumours results in inhibition of their lung metastases.
Mikysková R; Bubenik J; Mendoza L; Vonka V; Smahel M; Símová J; Jandlová T
Clin Exp Metastasis; 2000; 18(7):581-7. PubMed ID: 11688963
[TBL] [Abstract][Full Text] [Related]
23. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
Stagg J; Wu JH; Bouganim N; Galipeau J
Cancer Res; 2004 Dec; 64(24):8795-9. PubMed ID: 15604233
[TBL] [Abstract][Full Text] [Related]
24. Gene therapy with tumor vaccine increases the survival of hepatoma-bearing mice.
Chao Y; Shih YL; Cheng HJ; Wei SJ; Chi KH; Yeh SH; Lee SD; Yang WK
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Oct; 62(10):682-9. PubMed ID: 10533297
[TBL] [Abstract][Full Text] [Related]
25. Clinical phase I intratumoral administration of two recombinant ALVAC canarypox viruses expressing human granulocyte-macrophage colony-stimulating factor or interleukin-2: the transgene determines the composition of the inflammatory infiltrate.
Hofbauer GF; Baur T; Bonnet MC; Tartour E; Burg G; Berinstein NL; Dummer R
Melanoma Res; 2008 Apr; 18(2):104-11. PubMed ID: 18337646
[TBL] [Abstract][Full Text] [Related]
26. HPV 16-associated tumours: IL-12 can repair the absence of cytotoxic and proliferative responses of tumour infiltrating cells after chemotherapy.
Indrová M; Bieblová J; Rossowska J; Kuropka P; Pajtasz-Piasecka E; Bubeník J; Reinis M
Int J Oncol; 2009 Jan; 34(1):173-9. PubMed ID: 19082488
[TBL] [Abstract][Full Text] [Related]
27. Peritumoral administration of antigen-unstimulated bone marrow-derived dendritic cells inhibits tumour growth.
Mendoza L; Indrová M; Hájková R; Reinis M; Smahel M; Vonka V; Bubeník J; Jandlová T
Folia Biol (Praha); 2000; 46(3):91-7. PubMed ID: 10925779
[TBL] [Abstract][Full Text] [Related]
28. Combined immunization with DNA and transduced tumor cells expressing mouse GM-CSF or IL-2.
Rittich S; Duskova M; Mackova J; Pokorna D; Jinoch P; Smahel M
Oncol Rep; 2005 Feb; 13(2):311-7. PubMed ID: 15643517
[TBL] [Abstract][Full Text] [Related]
29. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
30. Depletion of T(reg) cells inhibits minimal residual disease after surgery of HPV16-associated tumours.
Símová J; Bubeník J; Bieblová J; Rosalia RA; Fric J; Reinis M
Int J Oncol; 2006 Dec; 29(6):1567-71. PubMed ID: 17088998
[TBL] [Abstract][Full Text] [Related]
31. Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer.
Kim SH; Carew JF; Kooby DA; Shields J; Entwisle C; Patel S; Shah JP; Fong Y
Cancer Gene Ther; 2000 Sep; 7(9):1279-85. PubMed ID: 11023201
[TBL] [Abstract][Full Text] [Related]
32. Metastatic MHC class I-negative mouse cells derived by transformation with human papillomavirus type 16.
Smahel M; Sobotková E; Bubeník J; Símová J; Zák R; Ludviková V; Hájková R; Kovarík J; Jelínek F; Povýsil C; Marinov J; Vonka V
Br J Cancer; 2001 Feb; 84(3):374-80. PubMed ID: 11225590
[TBL] [Abstract][Full Text] [Related]
33. Dissimilar anti-tumour reactions induced by tumour cells engineered with the interleukin-2 or interleukin-15 gene in nude mice.
Di Carlo E; Meazza R; Basso S; Rosso O; Comes A; Gaggero A; Musiani P; Santi L; Ferrini S
J Pathol; 2000 Jun; 191(2):193-201. PubMed ID: 10861581
[TBL] [Abstract][Full Text] [Related]
34. Anti-tumor effect of in vivo IL-2 and GM-CSF electrogene therapy in murine hepatoma model.
Chi CH; Wang YS; Lai YS; Chi KH
Anticancer Res; 2003; 23(1A):315-21. PubMed ID: 12680230
[TBL] [Abstract][Full Text] [Related]
35. Antitumor Effect on Murine Renal Cell Carcinoma by Autologous Tumor Vaccines Genetically Modified with Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-6 Cells.
Kinoshita Y; Kono T; Yasumoto R; Kishimoto T; Wang CY; Haas GP; Nishisaka N
J Immunother (1991); 2001 May; 24(3):205-211. PubMed ID: 11395635
[TBL] [Abstract][Full Text] [Related]
36. NK1.1+ cells are important for the development of protective immunity against MHC I-deficient, HPV16-associated tumours.
Indrová M; Símová J; Bieblová J; Bubeník J; Reinis M
Oncol Rep; 2011 Jan; 25(1):281-8. PubMed ID: 21109988
[TBL] [Abstract][Full Text] [Related]
37. Effect of GM-CSF and IL-2 co-expression on the anti-tumor immune response.
Lee SG; Heo DS; Yoon SJ; Jee YS; Kang JO; Kim K; Kim CD; Sung MW; Kim NK
Anticancer Res; 2000; 20(4):2681-6. PubMed ID: 10953343
[TBL] [Abstract][Full Text] [Related]
38. Combined immunization with fusion genes of mutated E7 gene of human papillomavirus type 16 did not enhance antitumor effect.
Pokorná D; Macková J; Dusková M; Rittich S; Ludvíková V; Smahel M
J Gene Med; 2005 Jun; 7(6):696-707. PubMed ID: 15712328
[TBL] [Abstract][Full Text] [Related]
39. Establishment and characterization of a rectal cancer model in mice: application to cytokine gene therapy.
Chen Y; Chang KJ; Hwang LH; Chen CN; Tseng SH
Int J Colorectal Dis; 2002 Nov; 17(6):388-95. PubMed ID: 12355214
[TBL] [Abstract][Full Text] [Related]
40. Comparative studies of the effects of recombinant GM-CSF and GM-CSF administered via a poxvirus to enhance the concentration of antigen- presenting cells in regional lymph nodes.
Kass E; Parker J; Schlom J; Greiner JW
Cytokine; 2000 Jul; 12(7):960-71. PubMed ID: 10880241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
